About Us > Board of Directors & Advisory Board

Board of Directors

Members of FORCE's board of directors have been personally affected by hereditary cancer or cancer risk, or have a strong interest in reaching out to others whose families have been devastated by this disease. Our board members are dedicated to fulfilling our mission by helping shape policies and strategies, connecting us to other organizations and assisting in outreach, research, education, advocacy, support and development.”

Teri Woodhull

Teri Woodhull, President

Teri Woodhull comes from a family with a long history of early-onset breast cancer; including her mother, grandmother and great-grandmother. She had a prophylactic mastectomy prior to the identification of the BRCA gene mutations in 1994. Read More...

Tara Freundlich

Tara Freundlich, Vice President

Tara Freundlich has been an active member of FORCE since learning of her BRCA 2 mutation in 2002. Tara has been a tireless advocate for the HBOC community. She helped to establish the FORCE helpline and she has logged over 1200 hours fielding calls. Read More...

Debbie Setuain

Debbie Setuain, Treasurer

Debbie Setuain is a daughter, a sister and a mother. She was born in Buenos Aires, Argentina. Her studies and work took her from Buenos Aires to Austin, Miami, Sao Paulo, Dallas, and finally Sunny Isles Beach, Florida.  Read More...

Carrie Catlin

Carrie Catlin, Secretary

Carrie Catlin, CFP® is a BRCA1+ previvor. She has been an active FORCE member and volunteer since 2006, acting as Boston Outreach Coordinator for several years in addition to hosting chat room sessions and speaking publicly about FORCE and genetic testing. Read More...

Ellyn Davidson

Ellyn Davidson

Ellyn Davidson was 36, the mother of a toddler, a Kindergartner and second-grader, and Account Director at Brogan & Partners when she was diagnosed with breast cancer. While fighting for her own life, she’s inspired hundreds of women to fight for theirs—personally and professionally.  Read More...

Sue Friedman

Sue Friedman

Dr. Sue Friedman was practicing small animal medicine in south Florida in 1996 when she was diagnosed “out of the blue” at age 33 with what appeared to be sporadic breast cancer. At the time, she was unaware of any familial risk factors for hereditary cancer.  Read More...

Elaine Kennedy

Elaine Kennedy

Elaine Kennedy was 31, recently married and a Marketing Director at a growing software company in the Washington, DC area when she was first diagnosed with breast cancer in 2000. After hearing the news, Elaine’s older sister decided to get checked ... Read More...

Tammy Li

Tammy Li

Tammy Li learned of the hereditary cancer in her family over 16 years ago when her firstborn was a newborn. She had previously had two early stage melanomas, but otherwise had never had a cancer diagnosis herself.  Read More... 

Judy Garber, MD – Director Emeritus

Judy E. Garber, MD is the director of the Cancer Genetics and Prevention Disease Center at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School. Dr. Garber founded the Friends of Dana-Farber Cancer Risk and Prevention Clinic, one of the first devoted to the identification and management of individuals at highest cancer risk. Read More...

David Nixon – Director Emeritus

David brings 23 years of healthcare experience and a record of entrepreneurial leadership to his role as CEO of InformedDNA. Since joining the company in 2007, David has transformed InformedDNA from the premier national genetic counseling provider network to the first-mover in the rapidly growing field of genetic testing utilization management. Read More...

Allison W. Kurian, MD – Director Emeritus

Dr. Kurian’s research focuses on the identification of women with elevated breast and gynecologic cancer risk, and on the development and evaluation of novel techniques for early cancer detection and risk reduction. She received her medical degree from Harvard Medical School and trained as a resident in Internal Medicine at the Massachusetts General Hospital. Read More... 
 

Rebecca Sutphen, MD – Director Emeritus

Dr. Rebecca Sutphen is a Professor of Genetics, University of South Florida Morsani College of Medicine, Tampa, FL and Chief Medical Officer of InformedDNA. Dr. Sutphen received her medical degree from Temple University, where she was elected to the National Honor Medical Society Alpha Omega Alpha. Read More...


Advisory Board.

Our advisory board is composed of health care experts who volunteer their time to assure the information we provide to our community is credible and up to date. Our advisory board members review the content available on our website, our publications, and in FORCE positions.

FORCE continues to add members to its health care and scientific advisory board.

Monica Alvarado, MS, CGC
Genetics Services Regional Administrator
Kaiser Permanente
Los Angeles, CA
(Cancer Genetic)

Deanna J. Attai, MD, FACS
Assistant Clinical Professor, Department of Surgery
UCLA David Geffen School of Medicine
UCLA Health Burbank Breast Care
(Breast Surgery)

Jennifer L Baker, MD
Assistant Professor of Surgery
UCLA David Geffen School of Medicine
Department of Surgery
(Breast Surgery)

Sharon Bober, PhD
Director, Sexual Health Program
Dana-Farber Cancer Institute/Harvard Medical School
(Sexual Health)

Rachel Brem, MD
Director of Breast Imaging & Intervention
George Washington University Department of Radiology
Washington, DC
(Radiology/Breast Imaging)

Alan Bryce, MD
Medical Director of the Genomic Oncology Clinic 
Mayo Clinic Arizona
Phoenix, AZ
(Medical Oncology, Prostate and Bladder Cancers) 

Lara Cartwright-Smith
The George Washington University
Milken Institute School of Public Health
Washington, DC 
(Health Policy)

Heather Cheng, MD, PhD
Associate Professor
University of Washington/Seattle Cancer Care Alliance
Seattle, WA
(Medical Oncology, Prostate and Bladder Cancers)

Mary Daly, MD, PhD
Chair, Department of Clinical Genetics
Fox Chase Cancer Center
Philadelphia, PA
(Medical Genetics)

Don S. Dizon, MD
Director of Women's Cancers,
Lifespan Cancer Institute
Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital
(Medical Oncology)

Susan Domchek, MD
Executive Director, Basser Research Center for BRCA
Director, MacDonald Women's Cancer Risk Evaluation Center
Basser Professor in Oncology, University of Pennsylvania
(Medical Oncology)

Debra Duquette, CGC
Associate Director
Feinberg School of Medicine, Division of Cardiology & Center for Genetic Medicine
Northwestern University
Chicago, IL
(Genetics)

Mark Fallick, MD, MBA
New Jersey Urology
Cherry Hill, NJ
(Urology and Fertility)

James Ford, MD
Director, Stanford Clinical Cancer Genetics Program
Stanford Cancer Center
Palo Alto, CA
(Cancer Genetics)

Gregory D Garber, MSW
Director Oncology Support Services
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, PA
(Oncology Support)

Judy E. Garber, MD, MPH
Director, Cancer Risk and Prevention Program
Dana-Farber Cancer Institute
Boston, MA
(Oncology and Cancer Genetics)

Veda N. Giri, MD
Associate Professor - Medical Oncology, Cancer Biology, and Urology
Director, Cancer Risk Assessment and Clinical Cancer Genetics
Sidney Kimmel Cancer Center
Thomas Jefferson University
(Genitourinary Oncology)

Michael J. Hall, MD, MS
Director GI Risk Assessment
Associate Professor of Medicine
Fox Chase Cancer Center
Philadelphia, PA
(Gastrointestinal Oncology and Genetic Risk)

Heather Hampel, CGC
Professor of Clinical Genetics
The Ohio State University
Columbus, OH
(Genetic Counseling)

Karen Hurley, PhD
Psychologist
Cleveland Clinic 
Cleveland, OH
(Clinical Psychology)

Steven Isakoff, MD, PhD
Massachusetts General Hospital
Boston, MA
(Breast Medical Oncology)

Joanne Jeter, MD
Associate Professor of Internal Medicine
University of Utah
Salt Lake City, UT

Bryson Katona, MD, PhD
Director, Gastrointestinal Cancer Genetics Program
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA
(Gastrointestinal Cancer Screening and Prevention)

Noah D. Kauff, MD
Director, Cancer Genetcs
Northwell Health Cancer Institute
(Cancer Genetics)

Andrew Kaunitz, MD
Associate Chair, Department of Obstetrics and Gynecology
University of Florida, College of Medicine, Jacksonville
Jacksonville, FL
(Gynecology/Menopause)

Jennifer Keating Litton, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, TX
(Breast Medical Oncology)

Jennifer R. Klemp, PhD, MPH
Risk Assessment Counselor and Program Manager of the Breast Cancer Survivorship Center
University of Kansas Medical Center
Kansas City, Kansas
(Cancer Risk Assessment Counseling)

Allison W. Kurian, MD, MSc
Assistant Professor of Medicine and of Health Research and Policy
Divisions of Oncology and Epidemiology
Stanford University School of Medicine
Stanford, CA
(Medical Oncology)

Christine Laronga, MD
Program Leader, Comprehensive Breast Program
Moffitt Cancer Center and Research Institute
Tampa, FL
(Breast Surgery)

Matthew Lederman, MD
RMA of New York
New York, NY
(Reproductive Endocrinology and Infertility)

Douglas Levine, MD
Director, Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center
NYU Langone Medical Center
New York, NY
(Gynecology/Oncology)

Joshua Levine, MD
Board Certified Plastic Surgeon, Microsurgical Breast Reconstruction
New York, NY
(Breast Reconstruction)

Catherine Marcum, APN, AGACNP-BC, AGN-BC, ACGN
Cleveland, TN
(Nurse Practitioner, Genetics)

Ellen Matloff, MS
President and CEO
My Gene Counsel
(Genetic Counseling)

Kara N. Maxwell MD, PhD
Instructor
University of Pennsylvania
Philadelphia, PA
(Medical Oncology/Cancer Genetics)

Bruce Montgomery, MD
Professor
University of Washington/Seattle Cancer Care Alliance
Seattle, WA
(Medical Oncology, Prostate and Bladder Cancers)

Bethany Niell, MD, PhD
Section Chief, Division of Breast Imaging, Department of Diagnostic Imaging
Moffitt Cancer Center
Tampa, FL
(Radiology/Breast Imaging)

Barbara Norquist, MD
Assistant Professor, Dept. of OB/GYN
University of Washington
(Gynecologic Oncology, Ovarian Cancer Prevention)

Allyson Ocean, MD
Weill Cornell Medicine
New York, NY
(Gastrointestinal oncology)

Kenneth Offit, MD
Chief, Clinical Genetics Service
Memorial Sloan Kettering Cancer Center
New York, NY
(Medical Oncology)

Nadereh Pourat, PhD
Professor, Department of Health Policy and Management
UCLA
Los Angeles, CA
(Health Policy)

Anya Prince, JD, MPP
University of Iowa College of Law
Iowa City, IA
(Legal and Insurance Issues)

Jana Pruski-Clark, CGC
Vice President, Cancer Genetics Services
InformedDNA
Roseville, CA
(Genetic Counseling)

Timothy R. Rebbeck, PhD
Professor Epidemiology, Harvard T.H. Chan School of Public Health, Professor Medical Oncology, Dana-Farber Cancer Institute
Boston, MA
(Epidemiology )

Kim A Reiss (Reiss Binder), M.D.
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Philadelphia, PA
(Medical Oncology)

BJ Rimel, MD
Cedars-Sinai Medical Center
Los Angeles, CA
(Gynecology/Oncology)

Jennifer Scalia Wilbur, MS
Clinical Program Manager/Cancer Genetic Counselor
Cancer Genetics and Prevention Program
Warren Alpert Medical School of Brown University Program in Women's Oncology
Women & Infants’Hospital
Providence, RI
(Genetic Counseling)

Victoria Seewaldt, MD
Professor and Chair, Department of Population Sciences
Associate Director, Comprehensive Cancer Center
City of Hope
Duarte, CA
(Medical Oncology)

Leigha Senter-Jamieson, CGC
Associate Professor
The Ohio State University
Columbus, OH
(Genetic Counseling)

Payal Shah, MD
Assistant Professor
Abramson Cancer Center
University of Pennsylvania
(Breast Medical Oncology)

Diljeet Singh, MD DrPh
Mid-Atlantic Permanante Medical Group
Washington, DC
(Gynecology/Oncology, Integrative Medicine)

Rebecca Sutphen, MD, FACMG
Professor of Genetics
College of Medicine
University of South Florida
Tampa, FL
(Genetics)

Elizabeth Swisher, MD
Department of Obstetrics & Gynecology
Medical Director, Breast and Ovarian Cancer Prevention Program
University of Washington School of Medicine
Seattle, WA
(Gynecology/Oncology)

Melinda Telli, MD
Assistant Professor of Medicine
Stanford University
Division of Medical Oncology
Stanford, CA
(Medical Oncology)

Kenneth Tercyak, PhD
Associate Professor
Leader, Cancer Prevention & Control Program
Director of Behavioral Prevention Research
Georgetown University Medical Center
Lombardi Cancer Center
Washington, DC
(Behavioarl Research)

Nadine M. Tung, MD
Beth Israel Deaconess Medical Center
Associate Professor, Medicine, Harvard Medical School
Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center
Boston, MA
(Medical Oncology/Cancer Genetics)

Matthew Yurgelun, MD
Director, Lynch Syndrome Center
Dana-Farber Cancer Institute
Boston, MA
(Gastrointestinal Oncology)

Updated 09/09/20